Trusted by:

clients clients clients clients clients clients clients clients clients clients
Newswise: Could a new medical approach fix faulty genes before birth?
Release date: 24-Oct-2024 2:00 PM EDT
Could a new medical approach fix faulty genes before birth?
UC Davis Health

A new biomedical tool successfully delivers genetic material to edit faulty genes in developing fetal brain cells. This might stop disease progression of genetic-based neurodevelopmental conditions before birth.

Newswise: A Cosmic Chemical Breakthrough: Astronomers Discover New Building Blocks for Complex Organic Matter
23-Oct-2024 2:00 PM EDT
A Cosmic Chemical Breakthrough: Astronomers Discover New Building Blocks for Complex Organic Matter
National Radio Astronomy Observatory

The element carbon is a building block for life, both on Earth and potentially elsewhere in the vast reaches of space. There should be a lot of carbon in space, but surprisingly, it's not always easy to find. While it can be observed in many places, it doesn’t add up to the volume astronomers would expect to see. The discovery of a new, complex molecule (1-cyanopyrene), challenges these expectations, about where the building blocks for carbon are found, and how they evolve. This research was published today in the journal Science.

Newswise: Beneficial Gut Microbe Has Surprising Metabolic Capabilities
22-Oct-2024 2:05 PM EDT
Beneficial Gut Microbe Has Surprising Metabolic Capabilities
Washington University in St. Louis

Researchers at Washington University School of Medicine in St. Louis have identified potentially far-reaching effects of a particular gut bacterium that was linked to better growth in Bangladeshi children receiving a therapeutic food designed to nurture healthy gut microbes. The far-reaching effects include regulating appetite, immune responses, neuronal function, and the ability of pathogenic bacteria to produce disease.

Newswise: For Heating Plasma in Fusion Devices, Researchers Unravel How Electrons Respond to Neutral Beam Injection
Release date: 24-Oct-2024 1:30 PM EDT
For Heating Plasma in Fusion Devices, Researchers Unravel How Electrons Respond to Neutral Beam Injection
Department of Energy, Office of Science

Plasmas for fusion research can be heated using neutral beam injection (NBI). With NBI, fast neutral particles from a beam source are injected into the plasma then ionized so that the particles can transfer energy to existing plasma electrons and ions. This transfers the ions’ energy and heats the plasma. Researchers recently studied the variation in electron temperature during NBI and used the data to experimentally determine the neutral beam deposition profile.

Release date: 24-Oct-2024 12:00 PM EDT
Expert Available: New Report Says Iranian Hackers Probed U.S. Election Websites in Swing States for Vulnerabilities
George Washington University

Microsoft says the probing took place in April and also included a dive into major U.S. media outlets, but this was only just discovered recently by Microsoft analysts. ...

Newswise: FSU researchers uncover new link between gut bacteria and Alzheimer’s disease
Release date: 24-Oct-2024 11:35 AM EDT
FSU researchers uncover new link between gut bacteria and Alzheimer’s disease
Florida State University

A groundbreaking study by researchers at Florida State University’s Gut Biome Lab has revealed a potential link between an infection caused by gut bacteria and the progression of Alzheimer’s disease. The research found that the bacteria Klebsiella pneumoniae — a common bacteria notorious for causing hospital-acquired infections — can migrate from the gut into the bloodstream and eventually into the brain.

Release date: 24-Oct-2024 11:25 AM EDT
Study Details Misuse of Scientific Publications by Opioid Industry
Johns Hopkins Bloomberg School of Public Health

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that makers and marketers of prescription opioid painkillers misused scientific evidence to advance five common and inaccurate claims about the safety and effectiveness of prescription opioids—including that they were not addictive.

Newswise: Combining targeted therapy and immunotherapy improves overall survival in patients with anaplastic thyroid cancer
24-Oct-2024 11:00 AM EDT
Combining targeted therapy and immunotherapy improves overall survival in patients with anaplastic thyroid cancer
University of Texas MD Anderson Cancer Center

Researchers from The University of Texas MD Anderson Cancer Center demonstrated that anti-PD-L1 immunotherapy in combination with mutation-directed targeted therapy extended overall survival (OS) in patients with anaplastic thyroid carcinoma (ATC).

Newswise: UCLA Researchers Engineer Experimental Drug for Preventing Heart Failure After Heart Attacks
23-Oct-2024 11:15 AM EDT
UCLA Researchers Engineer Experimental Drug for Preventing Heart Failure After Heart Attacks
University of California, Los Angeles (UCLA), Health Sciences

An experimental therapeutic monoclonal antibody therapy could become the first to directly enhance tissue repair in the heart following a heart attack.


close
1.77784